XML 28 R22.htm IDEA: XBRL DOCUMENT v3.2.0.727
Business Segment Information (Tables)
9 Months Ended
Jun. 30, 2015
Reconciliation from Segment Totals to Consolidated [Abstract]  
Reconciliation of Revenue from Segments to Consolidated Text Block

 

The following tables illustrate reportable segment information for the three and nine months ended June 30, 2015 and 2014 (in thousands):

 

 

Revenue

 

 

 

Three months ended

 

Nine months ended

 

 

 

June 30,

 

June 30,

 

 

 

2015

 

2014

 

2015

 

2014

 

Pharmaceutical Distribution

 

$

32,758,828

 

$

29,812,837

 

$

97,504,075

 

$

86,367,923

 

Other

 

1,532,907

 

620,275

 

3,214,977

 

1,796,910

 

Intersegment eliminations

 

(58,179

)

(84,958

)

(227,627

)

(184,414

)

 

 

 

 

 

 

 

 

 

 

Revenue

 

$

34,233,556

 

$

30,348,154

 

$

100,491,425

 

$

87,980,419

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Operating Profit Loss from Segments to Consolidated Text Block

 

 

Segment Operating Income

 

 

 

Three months ended

 

Nine months ended

 

 

 

June 30,

 

June 30,

 

 

 

2015

 

2014

 

2015

 

2014

 

Pharmaceutical Distribution

 

$

377,771 

 

$

359,795 

 

$

1,256,747 

 

$

1,019,506 

 

Other

 

77,372 

 

33,678 

 

186,688 

 

113,261 

 

 

 

 

 

 

 

 

 

 

 

Total segment operating income

 

$

455,143 

 

$

393,473 

 

$

1,443,435 

 

$

1,132,767 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Other Significant Reconciling Items from Segments to Consolidated Text Block

 

The following table reconciles total segment operating income to income (loss) from continuing operations before income taxes (in thousands):

 

 

 

Income (Loss) From Continuing

 

 

 

Operations Before Income Taxes

 

 

 

Three months ended

 

Nine months ended

 

 

 

June 30,

 

June 30,

 

 

 

2015

 

2014

 

2015

 

2014

 

Total segment operating income

 

$

455,143

 

$

393,473

 

$

1,443,435

 

$

1,132,767

 

Gains on antitrust litigation settlements

 

43,567

 

2,524

 

65,050

 

24,396

 

LIFO expense

 

(158,710

)

(133,237

)

(453,878

)

(293,647

)

Acquisition related intangibles amortization

 

(19,710

)

(5,701

)

(34,478

)

(17,484

)

Warrant expense

 

14,900

 

(145,040

)

(1,109,211

)

(267,000

)

Employee severance, litigation and other

 

(2,625

)

(1,142

)

(30,999

)

(7,411

)

 

 

 

 

 

 

 

 

 

 

Operating income (loss)

 

332,565

 

110,877

 

(120,081

)

571,621

 

Other (income) loss

 

(1,534

)

(1,312

)

11,185

 

(5,692

)

Interest expense, net

 

29,793

 

20,903

 

70,081

 

59,209

 

Loss on early retirement of debt

 

 

32,954

 

 

32,954

 

 

 

 

 

 

 

 

 

 

 

Income (loss) from continuing operations before income taxes

 

$

304,306

 

$

58,332

 

$

(201,347

)

$

485,150